Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
3
43%
Ph phase_4
4
57%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 4Post-market surveillance
4(57.1%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

42.9%

3 of 7 finished

Non-Completion Rate

57.1%

4 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(3)
Terminated(4)

Detailed Status

Completed3
Terminated2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Phase 44 (57.1%)
N/A3 (42.9%)

Trials by Status

terminated229%
withdrawn229%
completed343%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DEVICE
Total Trials
7